Results 41 to 50 of about 1,571,981 (263)

Patient outcomes, patient experiences and process indicators associated with the routine use of patient-reported outcome measures (PROMs) in cancer care: a systematic review

Supportive Care in Cancer, 2020
In current cancer care, there is a growing debate about the value of using patient-reported outcome measures (PROMs) in daily clinical follow-up. A systematic review of the literature was conducted to assess the evidence of the effectiveness of the ...
Caitlin Graupner, M. Kimman, S. Mul, A. Slok, D. Claessens, J. Kleijnen, C. Dirksen, S. Breukink   +7 more
semanticscholar   +1 more source

Visualization formats of patient-reported outcome measures in clinical practice: a systematic review about preferences and interpretation accuracy

Journal of Patient-Reported Outcomes, 2022
Purpose The use of Patient-Reported Outcome Measures (PROMs) for individual patient management within clinical practice is becoming increasingly important. New evidence about graphic visualization formats for PROMs scores has become available.
E. Albers, I. Fraterman, Iris Walraven, Erica Wilthagen, S. Schagen, I. M. van der Ploeg, M. Wouters, L. V. van de Poll-Franse, K. D. de Ligt   +8 more
semanticscholar   +1 more source

Questions of Copyright

Health and Quality of Life Outcomes, 2012
The Berne Convention and the national laws on intellectual property fully apply to PRO instruments. The identification of and access to an original PRO instrument is often associated with copyright ownership.
Anfray Caroline, Emery Marie-Pierre, Conway Katrin, Acquadro Catherine   +3 more
doaj   +1 more source

Patient-Reported Outcome Measures in Cancer Care

JAMA Network Open
Key Points Question How does the integration of patient-reported outcome measures (PROMs) affect outcomes of cancer care? Findings In this update to a systematic review and meta-analysis of 45 randomized clinical trials examining the use of PROMs for ...
Amaris K. Balitsky, Daniel Rayner, Joanne Britto, Anath C. Lionel, Lydia Ginsberg, Wanjae Cho, Ann Mary Wilfred, Huda Sardar, Nathan Cantor, Hira Mian, M. N. Levine, Gordon H. Guyatt   +11 more
semanticscholar   +1 more source

Patient-reported outcome measures used in patients undergoing total knee arthroplasty

Bone & Joint Research, 2021
Patient-reported outcome measures (PROMs) are being used increasingly in total knee arthroplasty (TKA). We conducted a systematic review aimed at identifying psychometrically sound PROMs by appraising their measurement properties.
Yiou Wang, Meihua Yin, Shibai Zhu, Xi Chen, Hongru Zhou, W. Qian   +5 more
semanticscholar   +1 more source

Sickle Cell Disease Is an Inherent Risk for Asthma in a Sibling Comparison Study

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Introduction Sickle cell disease (SCD) and asthma share a complex relationship. Although estimates vary, asthma prevalence in children with SCD is believed to be comparable to or higher than the general population. Determining whether SCD confers an increased risk for asthma remains challenging due to overlapping symptoms and the ...
Suhei C. Zuleta De Bernardis, Okeleji Olayinka, Mariam Z. Quraishi, Lakshmi V. Srivaths, Deborah L. Brown, Neethu M. Menon, Ricardo A. Mosquera, Ashwin P. Patel, James M. Stark, Aravind Yadav   +9 more
wiley   +1 more source

Adoption of electronic patient-reported outcomes in cancer clinical practice: the point of view of Italian patients

ESMO Real World Data and Digital Oncology
Background: In 2022, the European Society for Medical Oncology (ESMO) guideline recommended the adoption of electronic patient-reported outcomes measures (ePROMs) in routine clinical practice for patients with cancer.
A.A. Valsecchi, V. Battista, S. Terzolo, R. Dionisio, G. Lacidogna, D. Marino, V. Quarà, E. Sperti, V. Tuninetti, F. Vignani, C. Zichi, V.E. Bounous, G. Valabrega, A. Ferrero, N. Biglia, M. Di Maio   +15 more
doaj   +1 more source

Pazopanib Combined With Vincristine and Irinotecan in Relapsed Wilms Tumor: Encouraging Outcomes in a Heavily Pretreated Pediatric Cohort

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background While Wilms tumor (WT) typically has a favorable prognosis, relapsed cases—especially those with high‐risk histology—remain therapeutically challenging after intensive frontline therapy. The combination of vincristine and irinotecan has demonstrated activity in pediatric solid tumors, and pazopanib, a multi‐targeted tyrosine kinase ...
Maria Debora De Pasquale, Alessandro Crocoli, Giuseppe Maria Milano, Pierluigi Di Paolo, Francesca Diomedi Camassei, Ida Russo, Annalisa Serra   +6 more
wiley   +1 more source

Patient-reported outcome measures in oncology: a qualitative study of the healthcare professional’s perspective

Supportive Care in Cancer, 2021
In the last decades, the number of cancer survivors has increased significantly due to improved treatment and better detection of recurrence. This increased survival redirects the scope from survival towards optimising functional outcomes and improving ...
Caitlin Graupner, S. Breukink, S. Mul, D. Claessens, A. Slok, M. Kimman   +5 more
semanticscholar   +1 more source

Personalizing the Pediatric Hematology/Oncology Fellowship: Adapting Training for the Next Generation

Pediatric Blood &Cancer, EarlyView.
ABSTRACT The pediatric hematology‐oncology fellowship training curriculum has not substantially changed since its inception. The first year of training is clinically focused, and the second and third years are devoted to scholarship. However, this current structure leaves many fellows less competitive in the current job market, resulting in ...
Scott C. Borinstein, Melissa J. Rose, Scott Moerdler, Richard Ho   +3 more
wiley   +1 more source